Predicting relapse in major depression after successful initial pharmacological treatment

Area of Science:

• Psychiatry and Mental Health
• Clinical Psychology
• Pharmacology

Background:

• Major depression relapse is a significant clinical challenge.
• Individualized treatment strategies are needed to prevent relapse.
• Understanding relapse predictors is crucial for effective intervention.

Purpose of the Study:

• To identify predictors of depression relapse after achieving remission.
• To analyze demographic and clinical characteristics associated with relapse.
• To explore the role of residual symptoms and side effects in relapse.

Main Methods:

• Utilized data from a multicenter randomized trial of patients with major depression.
• Defined remission as Patient Health Questionnaire (PHQ-9) scores < 5 after 9 weeks of treatment.
• Defined relapse as PHQ-9 scores ≥ 5 at week 25, examining baseline and week 9 data.

Main Results:

• 14.4% of remitted patients (71/494) relapsed at week 25.
• Significant predictors of relapse included lower baseline depressive mood (PHQ-9 week 0), higher suicidal ideation (PHQ-9 week 0), residual symptoms (PHQ-9 week 9), and side effect severity (week 9).
• No significant predictors were found when relapse was defined as PHQ-9 score ≥ 10 at week 25.

Conclusions:

• Depression relapse within 4 months of remission affects approximately one-seventh of patients.
• Early depressive mood, suicidal ideation, residual symptoms, and side effect severity predict relapse.
• Findings may be sensitive to relapse definition; further research is needed.